This Slide: #72 of 100 |
Slide #72. Trinity Biotech plc — Immco Diagnostics Inc.
Acquirer:
Trinity Biotech plc (NASDAQ:TRIB)
Acquiree:
Immco Diagnostics Inc.
Details:
Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2013 and the acquisition of Immco Diagnostics Inc.
Trinity Biotech develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Co. is also a provider of raw materials to the life sciences and research industries globally. Co. markets its portfolio of products to customers through its own sales force and a network of international distributors and partners. The brand names of the products of Co. include UniGold, Recombigen, MarDx, FlexTrans, Premier, Ultr, ImmuBlot, ImmuGlo, ImmuLisa, OTOblot, EZ, and Captia.
Open the TRIB Page at The Online Investor »
|
Open the TRIB Page at The Online Investor (in a new window) »
Free TRIB Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (3.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |